id int64 | platform_type string | seller_id string | platform_name string | product_name string | product_category string | prescription_required_legally int64 | prescription_verified int64 | product_registered int64 | seller_licensed int64 | pharmacist_consultation int64 | verified_supply_chain int64 | cold_chain_maintained int64 | manufacturer_origin string | quality_test_result string | sf_classification string | API_content_adequate int64 | price_vs_reference float64 | payment_method string | consumer_age_group string | consumer_education string | consumer_complaint_filed int64 | adverse_event_reported int64 | website_takedown int64 | year int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
701 | social_media | EPHARM_00652 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.69 | bank_transfer | 18_24 | primary | 0 | 0 | 0 | 2,022 |
702 | social_media | EPHARM_00028 | marketplace_app | benzodiazepine | controlled | 1 | 1 | 1 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.4 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,021 |
703 | social_media | EPHARM_00324 | Facebook | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.74 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
704 | social_media | EPHARM_00607 | TikTok | antibiotic | prescription | 1 | 1 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.28 | bank_transfer | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
705 | social_media | EPHARM_00208 | Telegram | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.63 | mobile_money | 25_34 | primary | 0 | 0 | 0 | 2,020 |
706 | social_media | EPHARM_00105 | dedicated_website | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 1.02 | mobile_money | 18_24 | secondary | 0 | 0 | 0 | 2,023 |
707 | social_media | EPHARM_00520 | darknet_market | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.76 | cryptocurrency | 25_34 | tertiary | 0 | 0 | 0 | 2,021 |
708 | social_media | EPHARM_00756 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.63 | cryptocurrency | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
709 | social_media | EPHARM_00129 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 1.1 | cash_on_delivery | 25_34 | tertiary | 1 | 0 | 0 | 2,023 |
710 | social_media | EPHARM_00850 | TikTok | contraceptive | reproductive | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 0.33 | mobile_money | 25_34 | secondary | 1 | 0 | 0 | 2,024 |
711 | social_media | EPHARM_00839 | Facebook | antimalarial | essential | 1 | 1 | 1 | 0 | 1 | 1 | 0 | China | pass | compliant | 1 | 0.93 | bank_transfer | 18_24 | secondary | 0 | 0 | 0 | 2,020 |
712 | social_media | EPHARM_00927 | darknet_market | antidiabetic | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.66 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
713 | social_media | EPHARM_00537 | Facebook | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | falsified | 0 | 0.47 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
714 | social_media | EPHARM_00642 | dedicated_website | antidiabetic | NCD | 1 | 0 | 0 | 0 | 0 | 1 | 0 | local_SSA | pass | compliant | 1 | 0.59 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
715 | social_media | EPHARM_00533 | Facebook | COVID_treatment | pandemic | 0 | 0 | 1 | 0 | 0 | 0 | 1 | India | pass | compliant | 1 | 0.73 | mobile_money | 35_49 | secondary | 1 | 0 | 0 | 2,024 |
716 | social_media | EPHARM_00457 | dedicated_website | contraceptive | reproductive | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 1.05 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
717 | social_media | EPHARM_00560 | dedicated_website | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.47 | bank_transfer | 25_34 | secondary | 1 | 0 | 0 | 2,021 |
718 | social_media | EPHARM_00304 | WhatsApp | antidiabetic | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.26 | mobile_money | 18_24 | secondary | 1 | 0 | 0 | 2,022 |
719 | social_media | EPHARM_00097 | marketplace_app | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 1 | 0 | unknown | fail | falsified | 0 | 0.53 | bank_transfer | 35_49 | secondary | 0 | 0 | 0 | 2,021 |
720 | social_media | EPHARM_00062 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.57 | bank_transfer | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
721 | social_media | EPHARM_00027 | dedicated_website | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.97 | cash_on_delivery | 50_plus | primary | 0 | 0 | 0 | 2,024 |
722 | social_media | EPHARM_00634 | Telegram | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.93 | bank_transfer | 50_plus | secondary | 0 | 0 | 0 | 2,022 |
723 | social_media | EPHARM_00250 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 1 | unknown | fail | substandard | 0 | 0.75 | cash_on_delivery | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
724 | social_media | EPHARM_00434 | WhatsApp | opioid_analgesic | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | fail | falsified | 0 | 0.49 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
725 | social_media | EPHARM_00755 | marketplace_app | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.67 | mobile_money | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
726 | social_media | EPHARM_00502 | Telegram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.96 | credit_card | 18_24 | secondary | 0 | 0 | 0 | 2,022 |
727 | social_media | EPHARM_00524 | dedicated_website | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 0 | 0.46 | cryptocurrency | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
728 | social_media | EPHARM_00186 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.31 | credit_card | 35_49 | secondary | 0 | 0 | 0 | 2,023 |
729 | social_media | EPHARM_00215 | marketplace_app | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 0 | 0.52 | bank_transfer | 25_34 | tertiary | 1 | 0 | 0 | 2,024 |
730 | social_media | EPHARM_00171 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.65 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
731 | social_media | EPHARM_00938 | dedicated_website | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.48 | cash_on_delivery | 35_49 | primary | 0 | 0 | 0 | 2,024 |
732 | social_media | EPHARM_00554 | darknet_market | COVID_treatment | pandemic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.93 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
733 | social_media | EPHARM_00071 | marketplace_app | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.4 | credit_card | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
734 | social_media | EPHARM_00227 | Telegram | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 1 | Europe | fail | falsified | 0 | 0.78 | bank_transfer | 18_24 | secondary | 0 | 0 | 0 | 2,022 |
735 | social_media | EPHARM_00233 | marketplace_app | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.79 | bank_transfer | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
736 | social_media | EPHARM_00040 | Facebook | antidiabetic | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.41 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
737 | social_media | EPHARM_00512 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.59 | bank_transfer | 18_24 | secondary | 0 | 0 | 0 | 2,021 |
738 | social_media | EPHARM_00828 | Facebook | contraceptive | reproductive | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | pass | compliant | 1 | 0.52 | cash_on_delivery | 25_34 | tertiary | 0 | 0 | 0 | 2,022 |
739 | social_media | EPHARM_00529 | Telegram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.1 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,023 |
740 | social_media | EPHARM_00355 | WhatsApp | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.57 | bank_transfer | 18_24 | secondary | 1 | 0 | 0 | 2,024 |
741 | social_media | EPHARM_00303 | TikTok | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 1.01 | cash_on_delivery | 35_49 | secondary | 0 | 0 | 0 | 2,024 |
742 | social_media | EPHARM_00273 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.92 | credit_card | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
743 | social_media | EPHARM_00979 | dedicated_website | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 1.07 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
744 | social_media | EPHARM_00947 | marketplace_app | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.54 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,021 |
745 | social_media | EPHARM_00234 | darknet_market | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.86 | mobile_money | 35_49 | secondary | 1 | 0 | 0 | 2,022 |
746 | social_media | EPHARM_00314 | Instagram | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 1 | 0 | 0 | unknown | pass | compliant | 1 | 0.64 | credit_card | 18_24 | secondary | 0 | 0 | 0 | 2,024 |
747 | social_media | EPHARM_00604 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 0.95 | mobile_money | 35_49 | tertiary | 0 | 1 | 0 | 2,024 |
748 | social_media | EPHARM_00219 | Facebook | antidiabetic | NCD | 1 | 0 | 1 | 0 | 1 | 0 | 0 | unknown | fail | substandard | 0 | 0.59 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
749 | social_media | EPHARM_00943 | darknet_market | cancer_medicine | specialty | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 1 | 0.77 | mobile_money | 25_34 | primary | 0 | 0 | 0 | 2,023 |
750 | social_media | EPHARM_00801 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 0.83 | cash_on_delivery | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
751 | social_media | EPHARM_00803 | Telegram | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 0 | 0.62 | cash_on_delivery | 50_plus | secondary | 0 | 0 | 0 | 2,021 |
752 | social_media | EPHARM_00423 | darknet_market | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | India | fail | substandard | 0 | 0.62 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,020 |
753 | social_media | EPHARM_00314 | darknet_market | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.51 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
754 | social_media | EPHARM_00886 | darknet_market | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.63 | bank_transfer | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
755 | social_media | EPHARM_00769 | Telegram | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.72 | mobile_money | 35_49 | primary | 0 | 0 | 0 | 2,024 |
756 | social_media | EPHARM_00535 | darknet_market | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.36 | credit_card | 35_49 | secondary | 0 | 0 | 0 | 2,023 |
757 | social_media | EPHARM_00250 | Facebook | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.62 | cash_on_delivery | 25_34 | tertiary | 0 | 0 | 0 | 2,021 |
758 | social_media | EPHARM_00942 | dedicated_website | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.35 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
759 | social_media | EPHARM_00773 | dedicated_website | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | falsified | 0 | 0.63 | cash_on_delivery | 25_34 | tertiary | 1 | 0 | 0 | 2,024 |
760 | social_media | EPHARM_00610 | marketplace_app | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.67 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
761 | social_media | EPHARM_00051 | Facebook | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.79 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,021 |
762 | social_media | EPHARM_00910 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.49 | cash_on_delivery | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
763 | social_media | EPHARM_00820 | marketplace_app | cancer_medicine | specialty | 1 | 0 | 1 | 0 | 0 | 0 | 1 | India | fail | falsified | 0 | 0.64 | cryptocurrency | 35_49 | tertiary | 1 | 0 | 0 | 2,022 |
764 | social_media | EPHARM_00778 | dedicated_website | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.88 | mobile_money | 18_24 | secondary | 0 | 0 | 0 | 2,021 |
765 | social_media | EPHARM_00990 | marketplace_app | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 1 | 0.66 | credit_card | 18_24 | tertiary | 1 | 0 | 0 | 2,024 |
766 | social_media | EPHARM_00277 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 0.54 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,020 |
767 | social_media | EPHARM_00332 | dedicated_website | opioid_analgesic | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.76 | cash_on_delivery | 25_34 | secondary | 1 | 0 | 0 | 2,024 |
768 | social_media | EPHARM_00360 | Facebook | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.73 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
769 | social_media | EPHARM_00669 | TikTok | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 0 | 0.65 | bank_transfer | 18_24 | tertiary | 1 | 0 | 0 | 2,021 |
770 | social_media | EPHARM_00109 | dedicated_website | benzodiazepine | controlled | 1 | 1 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.69 | credit_card | 18_24 | tertiary | 0 | 0 | 0 | 2,021 |
771 | social_media | EPHARM_00766 | Facebook | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | USA | pass | compliant | 1 | 0.59 | mobile_money | 18_24 | primary | 0 | 0 | 0 | 2,023 |
772 | social_media | EPHARM_00726 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 1 | Europe | pass | compliant | 1 | 0.64 | mobile_money | 50_plus | secondary | 0 | 0 | 0 | 2,021 |
773 | social_media | EPHARM_00749 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.68 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
774 | social_media | EPHARM_00741 | marketplace_app | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.78 | mobile_money | 50_plus | primary | 0 | 0 | 0 | 2,023 |
775 | social_media | EPHARM_00135 | Facebook | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.65 | mobile_money | 35_49 | primary | 0 | 0 | 0 | 2,024 |
776 | social_media | EPHARM_00561 | WhatsApp | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.69 | cryptocurrency | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
777 | social_media | EPHARM_00344 | dedicated_website | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 1 | 0 | India | pass | compliant | 1 | 0.68 | credit_card | 18_24 | primary | 0 | 0 | 0 | 2,024 |
778 | social_media | EPHARM_00058 | dedicated_website | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.77 | cash_on_delivery | 50_plus | secondary | 0 | 0 | 0 | 2,022 |
779 | social_media | EPHARM_00995 | WhatsApp | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | India | fail | falsified | 0 | 0.29 | cash_on_delivery | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
780 | social_media | EPHARM_00527 | Facebook | benzodiazepine | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.58 | credit_card | 50_plus | tertiary | 0 | 0 | 0 | 2,023 |
781 | social_media | EPHARM_00187 | marketplace_app | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 1.02 | bank_transfer | 50_plus | secondary | 1 | 0 | 0 | 2,023 |
782 | social_media | EPHARM_00100 | marketplace_app | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.73 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
783 | social_media | EPHARM_00597 | Facebook | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 0.52 | cryptocurrency | 25_34 | secondary | 0 | 0 | 0 | 2,021 |
784 | social_media | EPHARM_00031 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.59 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
785 | social_media | EPHARM_00051 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.75 | cash_on_delivery | 35_49 | secondary | 0 | 0 | 0 | 2,024 |
786 | social_media | EPHARM_00323 | dedicated_website | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 1 | 0.72 | credit_card | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
787 | social_media | EPHARM_00017 | Facebook | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 1.05 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,022 |
788 | social_media | EPHARM_00147 | marketplace_app | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 1 | China | pass | compliant | 1 | 0.79 | cash_on_delivery | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
789 | social_media | EPHARM_00225 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 1 | unknown | fail | falsified | 1 | 0.5 | cryptocurrency | 18_24 | secondary | 0 | 0 | 0 | 2,022 |
790 | social_media | EPHARM_00661 | dedicated_website | cancer_medicine | specialty | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.71 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
791 | social_media | EPHARM_00204 | marketplace_app | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 1 | 0 | 0 | local_SSA | fail | substandard | 0 | 0.97 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,022 |
792 | social_media | EPHARM_00646 | marketplace_app | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.78 | credit_card | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
793 | social_media | EPHARM_00243 | marketplace_app | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.74 | mobile_money | 25_34 | primary | 0 | 0 | 0 | 2,022 |
794 | social_media | EPHARM_00391 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.8 | cash_on_delivery | 25_34 | tertiary | 1 | 0 | 0 | 2,023 |
795 | social_media | EPHARM_00624 | darknet_market | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.89 | credit_card | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
796 | social_media | EPHARM_00560 | Telegram | antihypertensive | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.86 | bank_transfer | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
797 | social_media | EPHARM_00501 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.64 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
798 | social_media | EPHARM_00043 | WhatsApp | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.62 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
799 | social_media | EPHARM_00036 | Instagram | benzodiazepine | controlled | 1 | 0 | 1 | 1 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.9 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
800 | social_media | EPHARM_00675 | WhatsApp | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 0.58 | cryptocurrency | 25_34 | tertiary | 1 | 0 | 0 | 2,024 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.